RSV, flu, COVID-19, norovirus on rise. See symptoms, facts

Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
What did a new FDA safety communication about two respiratory syncytial virus (RSV) vaccines warn about? Which company or ...
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and ...
The new CDC numbers on flu season will come out early next week. There was a delay because of federal offices being closed on ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...